CHEMFABNSEChemfab Alkalis LimitedHighNeutral
Announced Thu, 31 Jul, 2025 · 18:40 IST

Chemfab Alkalis Limited has submitted to the Exchange, the financial results for the period ended Jun 30, 2025.

Pat Growth 25pctExceptional ItemResults View source PDFExplain this filing

CHEMFAB · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
-9.7%Reaction day
₹792.90
prior close
₹795.00
announcement price
After-mkt
timing
Nifty Microcap 250market · in no size index; the smallest one is used-1.6%-8.1% vs market

On the reaction day the stock moved 8.1 pts less than Nifty Microcap 250, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
+2.3
10m
+6.2
15m
+3.8
30m
+3.1
Sessions after the filingfrom the prior close
StockMarketvs market
Reaction day
-9.7-1.6-8.1
Next day
-10.9-1.1-9.8
2d
-11.2-1.4-9.8
3d
-14.2-2.5-11.7
4d
-15.1-2.8-12.3
5d
-16.3-3.6-12.7
1w
-13.7-3.4-10.3
15d
-13.5-1.4-12.1
1m
-16.0-2.7-13.3
2m
-20.9-3.1-17.9
3m
-25.8+0.4-26.3
UpDownMarket · Nifty Microcap 250Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Chemfab Alkalis posted strong Q1 FY26 results with standalone revenue rising about 15% year-on-year to Rs. 87.58 crores and standalone net profit jumping roughly 62% to Rs. 5.39 crores. Consolidated revenue grew nearly 19% to Rs. 91.54 crores while consolidated net profit surged about 184% to Rs. 2.55 crores, partly aided by a lower depreciation charge after the company reassessed the useful life of certain PVC-O division plant and machinery. The PVC-O Pipes segment remained the main profit driver with a pre-tax segment profit of Rs. 8.63 crores, whereas the Chemicals segment again slipped into a small pre-tax loss of Rs. 0.59 crores. Separately, the board allotted 4,000 ESOP shares under the CAESOS 2020 scheme, approved amendments to the scheme, and accepted the resignation of non-executive director Mr. C. S. Ramesh, leading to reconstitution of the Audit, Nomination & Remuneration, CSR, and Stakeholders Relationship committees. The limited review report from Deloitte Haskins & Sells LLP was clean with no qualifications or emphasis-of-matter paragraphs.

Likely market impact

The sharp jump in profits, especially at the consolidated level, is a positive signal for shareholders, though the underlying chemicals business remains a drag. The change in depreciation estimate is a one-time accounting boost that will flatter reported earnings for several quarters going forward, while the board-level changes appear routine and unlikely to materially affect the stock.